Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey

Abstract This retrospective study was undertaken to provide more modern data of real-life management of non-metastatic rectal cancer, to compare therapeutic strategies, and to identify prognostic factors of overall survival (OS) in a large cohort of patients. Data on efficacy and on acute/late toxic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Julien Langrand-Escure, Peng Diao, Max-Adrien Garcia, Guoping Wang, Jean-Baptiste Guy, Sophie Espenel, Elodie Guillaume, Amel Rehailia-Blanchard, Grégoire Pigné, Guy de Laroche, David Kaczmarek, Thierry Muron, Jack Porcheron, Jean-Marc Phelip, Alexis Vallard, Nicolas Magné
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/ba1f95710e8b40e4b3ba3fc05ee9b3ae
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ba1f95710e8b40e4b3ba3fc05ee9b3ae
record_format dspace
spelling oai:doaj.org-article:ba1f95710e8b40e4b3ba3fc05ee9b3ae2021-12-02T15:07:58ZOutcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey10.1038/s41598-018-29040-22045-2322https://doaj.org/article/ba1f95710e8b40e4b3ba3fc05ee9b3ae2018-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-29040-2https://doaj.org/toc/2045-2322Abstract This retrospective study was undertaken to provide more modern data of real-life management of non-metastatic rectal cancer, to compare therapeutic strategies, and to identify prognostic factors of overall survival (OS) in a large cohort of patients. Data on efficacy and on acute/late toxicity were retrospectively collected. Patients were diagnosed a non-metastatic rectal cancer between 2004 and 2015, and were treated at least with radiotherapy. OS was correlated with patient, tumor and treatment characteristics with univariate and multivariate analyses. Data of 593 consecutive non-metastatic rectal cancer patients were analyzed. Median follow-up was 41 months. Median OS was 9 years. Radiotherapy was delivered in pre-operative (n = 477, 80.5%), post-operative (n = 75, 12.6%) or exclusive (n = 41, 6.9%) setting. In the whole set of patients, age, nutritional condition, tumor stage, tumor differentiation, and surgery independently influenced OS. For patients experiencing surgery, OS was influenced by age, tumor differentiation and nodal status. Surgical resection is the cornerstone treatment for locally-advanced rectal cancer. Poor tumor differentiation and node involvement were identified as major predictive factor of poor OS. The research in treatment intensification and in identification of radioresistance biomarkers should therefore probably be focused on this particular subset of patients.Julien Langrand-EscurePeng DiaoMax-Adrien GarciaGuoping WangJean-Baptiste GuySophie EspenelElodie GuillaumeAmel Rehailia-BlanchardGrégoire PignéGuy de LarocheDavid KaczmarekThierry MuronJack PorcheronJean-Marc PhelipAlexis VallardNicolas MagnéNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Julien Langrand-Escure
Peng Diao
Max-Adrien Garcia
Guoping Wang
Jean-Baptiste Guy
Sophie Espenel
Elodie Guillaume
Amel Rehailia-Blanchard
Grégoire Pigné
Guy de Laroche
David Kaczmarek
Thierry Muron
Jack Porcheron
Jean-Marc Phelip
Alexis Vallard
Nicolas Magné
Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey
description Abstract This retrospective study was undertaken to provide more modern data of real-life management of non-metastatic rectal cancer, to compare therapeutic strategies, and to identify prognostic factors of overall survival (OS) in a large cohort of patients. Data on efficacy and on acute/late toxicity were retrospectively collected. Patients were diagnosed a non-metastatic rectal cancer between 2004 and 2015, and were treated at least with radiotherapy. OS was correlated with patient, tumor and treatment characteristics with univariate and multivariate analyses. Data of 593 consecutive non-metastatic rectal cancer patients were analyzed. Median follow-up was 41 months. Median OS was 9 years. Radiotherapy was delivered in pre-operative (n = 477, 80.5%), post-operative (n = 75, 12.6%) or exclusive (n = 41, 6.9%) setting. In the whole set of patients, age, nutritional condition, tumor stage, tumor differentiation, and surgery independently influenced OS. For patients experiencing surgery, OS was influenced by age, tumor differentiation and nodal status. Surgical resection is the cornerstone treatment for locally-advanced rectal cancer. Poor tumor differentiation and node involvement were identified as major predictive factor of poor OS. The research in treatment intensification and in identification of radioresistance biomarkers should therefore probably be focused on this particular subset of patients.
format article
author Julien Langrand-Escure
Peng Diao
Max-Adrien Garcia
Guoping Wang
Jean-Baptiste Guy
Sophie Espenel
Elodie Guillaume
Amel Rehailia-Blanchard
Grégoire Pigné
Guy de Laroche
David Kaczmarek
Thierry Muron
Jack Porcheron
Jean-Marc Phelip
Alexis Vallard
Nicolas Magné
author_facet Julien Langrand-Escure
Peng Diao
Max-Adrien Garcia
Guoping Wang
Jean-Baptiste Guy
Sophie Espenel
Elodie Guillaume
Amel Rehailia-Blanchard
Grégoire Pigné
Guy de Laroche
David Kaczmarek
Thierry Muron
Jack Porcheron
Jean-Marc Phelip
Alexis Vallard
Nicolas Magné
author_sort Julien Langrand-Escure
title Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey
title_short Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey
title_full Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey
title_fullStr Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey
title_full_unstemmed Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey
title_sort outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/ba1f95710e8b40e4b3ba3fc05ee9b3ae
work_keys_str_mv AT julienlangrandescure outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey
AT pengdiao outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey
AT maxadriengarcia outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey
AT guopingwang outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey
AT jeanbaptisteguy outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey
AT sophieespenel outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey
AT elodieguillaume outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey
AT amelrehailiablanchard outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey
AT gregoirepigne outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey
AT guydelaroche outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey
AT davidkaczmarek outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey
AT thierrymuron outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey
AT jackporcheron outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey
AT jeanmarcphelip outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey
AT alexisvallard outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey
AT nicolasmagne outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey
_version_ 1718388344395661312